Concentrix Corporation

NASDAQ:CNXC

Information Technology Services

Technology
$30.63 -2.95%

-$0.75 today

Market cap
$1.87B
Beta
0.42
P/E (TTM)
-1.1
EPS (TTM)
-$21.66
Dividend yield
5.73%
52W Low $22.05High $62.14

Volume 0.74M

Average 1.64M

CNXC Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

Concentrix CorporationNASDAQ: CNXC

Research & Development · Q1 FY2026 · quarter ended Feb 2026

Research & development remains negative

Q1 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.

Context

  • Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
  • Research & development increased in 0 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterFeb 2026
$0— QoQ
Last fiscal yearNov 2025
$0— YoY
LTMFeb 2026
$0— YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Research & Development history

USD · from the income statement

Latest · FY2025
0 USD
Year-over-year change
—

Research & Development vs competitors

How CNXC compares with its peers on the latest reported figures

  • CNXC's LTM Feb 2026 research & development of $0 is the 4th highest of the 9 companies compared; the peer median is $0.
  • Research & development amounts to 0.0% of revenue for CNXC, versus a peer median of 0.0%.
CNXC Competitors Peer median
Research & Development for CNXC and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CXMSprinklr, Inc.LTM Apr 2026$96.55M +5.1%+7.8%11.1%
GDYNGrid Dynamics Holdings, Inc.LTM Mar 2026$23.26M +13.7%+14.5%5.6%
INODInnodata Inc.LTM Jun 2026$1M +11.1%—0.3%
CNXCConcentrix CorporationLTM Feb 2026$0 ——0.0%
EPAMEPAM Systems, Inc.LTM Sep 2026$0 ——0.0%
EXLSExlService Holdings, Inc.LTM Jun 2026$0 ——0.0%
CLVTClarivate PlcLTM Mar 2026$0 ——0.0%
IBEXIBEX LimitedLTM Mar 2026$0 ——0.0%
TTECTTEC Holdings, Inc.LTM Mar 2026$0 -100.0%—0.0%
Peer median (excluding CNXC) $0+8.1%+11.1%0.0%

Competitors are the stored peer set for CNXC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Nov 2021
FY2022
Nov 2022
FY2023
Nov 2023
FY2024
Nov 2024
FY2025
Nov 2025
Revenue5.59B6.32B7.11B9.62B9.83B
Cost of Revenue3.62B4.07B4.54B6.17B6.39B
Gross Profit1.97B2.26B2.58B3.45B3.44B
Gross Margin35.3%35.7%36.2%35.9%35.0%
Research & Development00000
Selling, General & Admin1.4B1.62B1.92B2.85B2.83B
Operating Expenses1.4B1.62B1.92B2.85B2.83B
Depreciation & Amortization277.18M309.54M388.3M705.85M650.11M
EBITDA855.92M984.62M997.53M1.33B(241.77M)
EBITDA Margin15.3%15.6%14.0%13.8%-2.5%
Operating Income572.4M640.19M661.33M596.39M609.54M
Operating Margin10.2%10.1%9.3%6.2%6.2%
Interest Income00000
Interest Expense23.05M70.08M201M321.83M290.35M
Other Income / Expenses(16.7M)(35.19M)(253.1M)(297.11M)(1.79B)
Income Before Tax555.7M605M408.23M299.27M(1.18B)
Pre-Tax Margin9.9%9.6%5.7%3.1%-12.0%
Income Tax Expense150.12M169.36M94.39M48.06M96.7M
Net Income405.58M435.05M313.84M251.22M(1.28B)
Net Margin7.3%6.9%4.4%2.6%-13.0%
EPS (Basic)7.788.345.723.72(20.36)
EPS (Diluted)7.708.285.703.71(20.36)
Weighted Avg Shares51.36M51.35M53.8M64.98M63.01M
Weighted Avg Shares (Diluted)51.91M51.74M54.01M65.07M63.01M

Concentrix Corporation

NASDAQ:CNXC

Intrinsic Alpha fair value

Locked

Current Price

$30.63

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.